Metoprolol 50mg

Metoprolol Tartrate, the active ingredient in Metoprolol 50mg, is a beta blocker presented as a 50 mg oral dosage form for oral use. It is employed to lower blood pressure, relieve angina and control heart rate in various cardiac conditions.

GNH USA supplies Metoprolol 50mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol acts on the cardiovascular system to reduce heart rate and myocardial oxygen demand, making it useful for several heart‑related conditions.

- Hypertension: lowers blood pressure by decreasing cardiac output and renin release. - Angina pectoris: reduces chest pain by limiting heart work and oxygen consumption. - Post‑myocardial infarction: helps prevent recurrent events by stabilising heart rhythm and reducing workload. - Chronic heart failure: improves survival by decreasing sympathetic stimulation and ventricular stress. - Arrhythmias (e.g., atrial fibrillation): slows ventricular response through β1‑receptor blockade.

Metoprolol may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and less frequent side effects.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness. - Bradycardia (slow heart rate). - Cold extremities or peripheral vasoconstriction. - Gastrointestinal upset such as nausea. - Sleep disturbances or vivid dreams.

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Marked hypotension. - Bronchospasm, especially in asthmatic patients. - Allergic reactions including rash or angioedema. - Depression or mood changes. - Worsening heart failure symptoms.

Before initiating Metoprolol, clinicians should evaluate patient history and monitor key parameters.

- Cardiovascular assessment: confirm stable heart rate and blood pressure. - Monitor heart rate and blood pressure regularly during therapy. - Use caution in patients with asthma or chronic obstructive pulmonary disease. - Avoid abrupt discontinuation to prevent rebound hypertension. - Adjust dose in renal or hepatic impairment as needed. - Store at ambient temperature: keep in the original container, protect from moisture.

Metoprolol can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Concomitant use with non‑selective beta blockers may cause excessive β‑blockade. - Combined with calcium‑channel blockers such as verapamil or diltiazem can lead to severe bradycardia. - Potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) increase metoprolol plasma levels. - Co‑administration with clonidine may precipitate hypertension on withdrawal.

Moderate Interactions (Monitor Closely): - Diuretics may enhance the hypotensive effect of metoprolol. - NSAIDs can attenuate its antihypertensive efficacy. - Insulin or oral hypoglycemics may mask hypoglycaemia symptoms.